Skip to main content
Erschienen in: Neurocritical Care 1/2017

15.09.2017

Emergency Neurological Life Support: Acute Non-traumatic Weakness

verfasst von: Anna Finley Caulfield, Oliver Flower, Jose A. Pineda, Shahana Uddin

Erschienen in: Neurocritical Care | Sonderheft 1/2017

Einloggen, um Zugang zu erhalten

Abstract

Acute non-traumatic weakness may be life-threatening if it involves the respiratory muscles and/or is associated with autonomic dysfunction. Most patients presenting with acute muscle weakness have a worsening neurological disorder that requires a rapid, systematic evaluation and detailed neurological exam to localize the disorder. Urgent laboratory tests and neuroimaging are needed to confirm the diagnosis. Because acute weakness is a common presenting sign of neurological emergencies, it was chosen as an Emergency Neurological Life Support protocol. Causes of acute non-traumatic weakness are discussed here by both presenting clinical signs and anatomical location. For each diagnosis, key features of the history, examination, investigations, and treatment are outlined in the included tables or in the “Appendix”.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care. 2006;51:1016–21 (discussion 1021–3).PubMed Mehta S. Neuromuscular disease causing acute respiratory failure. Respir Care. 2006;51:1016–21 (discussion 1021–3).PubMed
2.
Zurück zum Zitat Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain–Barre syndrome. Arch Neurol. 2001;58:893–8.CrossRefPubMed Lawn ND, Fletcher DD, Henderson RD, Wolter TD, Wijdicks EF. Anticipating mechanical ventilation in Guillain–Barre syndrome. Arch Neurol. 2001;58:893–8.CrossRefPubMed
3.
Zurück zum Zitat Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mt Sinai J Med. 2002;69:31–7.PubMed Abel M, Eisenkraft JB. Anesthetic implications of myasthenia gravis. Mt Sinai J Med. 2002;69:31–7.PubMed
4.
Zurück zum Zitat Orebaugh SL. Succinylcholine: adverse effects and alternatives in emergency medicine. Am J Emerg Med. 1999;17:715–21.CrossRefPubMed Orebaugh SL. Succinylcholine: adverse effects and alternatives in emergency medicine. Am J Emerg Med. 1999;17:715–21.CrossRefPubMed
5.
Zurück zum Zitat Zuccoli G, Panigrahy A, Bailey A, Fitz C. Redefining the Guillain–Barre spectrum in children: neuroimaging findings of cranial nerve involvement. Am J Neuroradiol. 2011;32:639–42.CrossRefPubMed Zuccoli G, Panigrahy A, Bailey A, Fitz C. Redefining the Guillain–Barre spectrum in children: neuroimaging findings of cranial nerve involvement. Am J Neuroradiol. 2011;32:639–42.CrossRefPubMed
6.
Zurück zum Zitat Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology. 2007;68:1474–80.CrossRefPubMed Pidcock FS, Krishnan C, Crawford TO, Salorio CF, Trovato M, Kerr DA. Acute transverse myelitis in childhood: center-based analysis of 47 cases. Neurology. 2007;68:1474–80.CrossRefPubMed
7.
Zurück zum Zitat Chen L, Li J, Guo Z, Liao S, Jiang L. Prognostic indicators of acute transverse myelitis in 39 children. Pediatric Neurol. 2013;49:397–400.CrossRef Chen L, Li J, Guo Z, Liao S, Jiang L. Prognostic indicators of acute transverse myelitis in 39 children. Pediatric Neurol. 2013;49:397–400.CrossRef
8.
Zurück zum Zitat Wolf VL, Lupo PJ, Lotze TE. Pediatric acute transverse myelitis overview and differential diagnosis. J Child Neurol. 2012;27:1426–36.CrossRefPubMed Wolf VL, Lupo PJ, Lotze TE. Pediatric acute transverse myelitis overview and differential diagnosis. J Child Neurol. 2012;27:1426–36.CrossRefPubMed
9.
Zurück zum Zitat Bernard T, Rivkin M, Scholz K, deVeber G, Kirton A, Gill JC, Chan A, Hovinga C, Ichord R, Grotta J, Jordan L, Benedict S, Friedman N, Dowling M, Elbers J, Torres M, Sultan S, Cummings D, Grabowski E, McMillan H, Beslow L, Amlie-Lefond C. Emergence of the primary pediatric stroke center: impact of the thrombolysis in pediatric stroke trial. Stroke. 2014;45:2018–23.CrossRefPubMedPubMedCentral Bernard T, Rivkin M, Scholz K, deVeber G, Kirton A, Gill JC, Chan A, Hovinga C, Ichord R, Grotta J, Jordan L, Benedict S, Friedman N, Dowling M, Elbers J, Torres M, Sultan S, Cummings D, Grabowski E, McMillan H, Beslow L, Amlie-Lefond C. Emergence of the primary pediatric stroke center: impact of the thrombolysis in pediatric stroke trial. Stroke. 2014;45:2018–23.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Novy J, Carruzzo A, Maeder P, Bogousslavsky J. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol. 2006;63:1113–20.CrossRefPubMed Novy J, Carruzzo A, Maeder P, Bogousslavsky J. Spinal cord ischemia: clinical and imaging patterns, pathogenesis, and outcomes in 27 patients. Arch Neurol. 2006;63:1113–20.CrossRefPubMed
11.
Zurück zum Zitat Brinar VV, Habek M, Brinar M, Malojcic B, Boban M. The differential diagnosis of acute transverse myelitis. Clin Neurol Neurosurg. 2006;108:278–83.CrossRefPubMed Brinar VV, Habek M, Brinar M, Malojcic B, Boban M. The differential diagnosis of acute transverse myelitis. Clin Neurol Neurosurg. 2006;108:278–83.CrossRefPubMed
12.
Zurück zum Zitat DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab. 2004;287:E32–41.CrossRefPubMed DeRosa MA, Cryer PE. Hypoglycemia and the sympathoadrenal system: neurogenic symptoms are largely the result of sympathetic neural, rather than adrenomedullary, activation. Am J Physiol Endocrinol Metab. 2004;287:E32–41.CrossRefPubMed
15.
Zurück zum Zitat White J. Venomous animals: clinical toxinology. EXS. 2010;100:233–91.PubMed White J. Venomous animals: clinical toxinology. EXS. 2010;100:233–91.PubMed
17.
Zurück zum Zitat Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897–903.CrossRefPubMed Hagan PG, Nienaber CA, Isselbacher EM, et al. The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease. JAMA. 2000;283:897–903.CrossRefPubMed
18.
Zurück zum Zitat Gaul C, Dietrich W, Friedrich I, Sirch J, Erbguth FJ. Neurological symptoms in type A aortic dissections. Stroke. 2007;38:292–7.CrossRefPubMed Gaul C, Dietrich W, Friedrich I, Sirch J, Erbguth FJ. Neurological symptoms in type A aortic dissections. Stroke. 2007;38:292–7.CrossRefPubMed
19.
20.
Zurück zum Zitat Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24:135–46.CrossRefPubMed Aggarwal M, Khan IA. Hypertensive crisis: hypertensive emergencies and urgencies. Cardiol Clin. 2006;24:135–46.CrossRefPubMed
22.
Zurück zum Zitat Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141–9.CrossRefPubMed Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141–9.CrossRefPubMed
23.
Zurück zum Zitat Meriggioli MN, Sanders DB. Advances in the diagnosis of neuromuscular junction disorders. Am J Phys Med Rehabil. 2005;84:627–38.CrossRefPubMed Meriggioli MN, Sanders DB. Advances in the diagnosis of neuromuscular junction disorders. Am J Phys Med Rehabil. 2005;84:627–38.CrossRefPubMed
24.
Zurück zum Zitat Headache Classification Subcommittee of the International Headache, Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160. Headache Classification Subcommittee of the International Headache, Society. The international classification of headache disorders: 2nd edition. Cephalalgia. 2004;24(Suppl 1):9–160.
25.
Zurück zum Zitat Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10:457–70.CrossRefPubMed Russell MB, Ducros A. Sporadic and familial hemiplegic migraine: pathophysiological mechanisms, clinical characteristics, diagnosis, and management. Lancet Neurol. 2011;10:457–70.CrossRefPubMed
26.
Zurück zum Zitat Guisado R, Arieff AI. Neurologic manifestations of diabetic comas: correlation with biochemical alterations in the brain. Metabolism. 1975;24:665–79.CrossRefPubMed Guisado R, Arieff AI. Neurologic manifestations of diabetic comas: correlation with biochemical alterations in the brain. Metabolism. 1975;24:665–79.CrossRefPubMed
27.
28.
Zurück zum Zitat Gallmetzer P, Leutmezer F, Serles W, Assem-Hilger E, Spatt J, Baumgartner C. Postictal paresis in focal epilepsies—incidence, duration, and causes: a video-EEG monitoring study. Neurology. 2004;62:2160–4.CrossRefPubMed Gallmetzer P, Leutmezer F, Serles W, Assem-Hilger E, Spatt J, Baumgartner C. Postictal paresis in focal epilepsies—incidence, duration, and causes: a video-EEG monitoring study. Neurology. 2004;62:2160–4.CrossRefPubMed
29.
Zurück zum Zitat Rolak LA, Rutecki P, Ashizawa T, Harati Y. Clinical features of Todd’s post-epileptic paralysis. J Neurol Neurosurg Psychiatry. 1992;55:63–4.CrossRefPubMedPubMedCentral Rolak LA, Rutecki P, Ashizawa T, Harati Y. Clinical features of Todd’s post-epileptic paralysis. J Neurol Neurosurg Psychiatry. 1992;55:63–4.CrossRefPubMedPubMedCentral
31.
32.
Zurück zum Zitat Sayer FT, Vitali AM, Low HL, Paquette S, Honey CR. Brown-Sequard syndrome produced by C3–C4 cervical disc herniation: a case report and review of the literature. Spine. 2008;33:E279–82.CrossRefPubMed Sayer FT, Vitali AM, Low HL, Paquette S, Honey CR. Brown-Sequard syndrome produced by C3–C4 cervical disc herniation: a case report and review of the literature. Spine. 2008;33:E279–82.CrossRefPubMed
33.
Zurück zum Zitat Antich PA, Sanjuan AC, Girvent FM, Simo JD. High cervical disc herniation and Brown-Sequard syndrome. A case report and review of the literature. J Bone Joint Surg Br. 1999;81:462–3.CrossRefPubMed Antich PA, Sanjuan AC, Girvent FM, Simo JD. High cervical disc herniation and Brown-Sequard syndrome. A case report and review of the literature. J Bone Joint Surg Br. 1999;81:462–3.CrossRefPubMed
34.
Zurück zum Zitat Bruno MA, Pellas F, Schnakers C, et al. Blink and you live: the locked-in syndrome. Rev Neurol (Paris). 2008;164:322–35.CrossRef Bruno MA, Pellas F, Schnakers C, et al. Blink and you live: the locked-in syndrome. Rev Neurol (Paris). 2008;164:322–35.CrossRef
35.
Zurück zum Zitat Puetz V, Sylaja PN, Coutts SB, et al. Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. Stroke. 2008;39:2485–90.CrossRefPubMed Puetz V, Sylaja PN, Coutts SB, et al. Extent of hypoattenuation on CT angiography source images predicts functional outcome in patients with basilar artery occlusion. Stroke. 2008;39:2485–90.CrossRefPubMed
39.
Zurück zum Zitat Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain–Barre syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608–13.CrossRefPubMed Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain–Barre syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608–13.CrossRefPubMed
40.
Zurück zum Zitat Ropper AH. Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol. 1994;51:671–5.CrossRefPubMed Ropper AH. Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol. 1994;51:671–5.CrossRefPubMed
41.
Zurück zum Zitat Hughes RA, Swan AV, van Koningsveld R, van Doorn PA. Corticosteroids for Guillain–Barré syndrome. Cochrane Database Syst Rev. 2006;19(2):CD001446. Hughes RA, Swan AV, van Koningsveld R, van Doorn PA. Corticosteroids for Guillain–Barré syndrome. Cochrane Database Syst Rev. 2006;19(2):CD001446.
42.
Zurück zum Zitat Varma JK, Katsitadze G, Moiscrafishvili M, et al. Signs and symptoms predictive of death in patients with foodborne botulism—Republic of Georgia, 1980–2002. Clin Infect Dis. 2004;39:357–62.CrossRefPubMed Varma JK, Katsitadze G, Moiscrafishvili M, et al. Signs and symptoms predictive of death in patients with foodborne botulism—Republic of Georgia, 1980–2002. Clin Infect Dis. 2004;39:357–62.CrossRefPubMed
44.
Zurück zum Zitat Chalk C, Benstead TJ, Keezer M. Medical treatment for botulism. Cochrane Database Syst Rev. 2011;16(3):CD008123. Chalk C, Benstead TJ, Keezer M. Medical treatment for botulism. Cochrane Database Syst Rev. 2011;16(3):CD008123.
45.
Zurück zum Zitat Graeme KA, Pollack CV Jr. Heavy metal toxicity, part I: arsenic and mercury. J Emerg Med. 1998;16:45–56.CrossRefPubMed Graeme KA, Pollack CV Jr. Heavy metal toxicity, part I: arsenic and mercury. J Emerg Med. 1998;16:45–56.CrossRefPubMed
46.
Zurück zum Zitat Graeme KA, Pollack CV Jr. Heavy metal toxicity, part II: lead and metal fume fever. J Emerg Med. 1998;16:171–7.CrossRefPubMed Graeme KA, Pollack CV Jr. Heavy metal toxicity, part II: lead and metal fume fever. J Emerg Med. 1998;16:171–7.CrossRefPubMed
47.
Zurück zum Zitat Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev. 2000;22:298–316.CrossRefPubMed Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev. 2000;22:298–316.CrossRefPubMed
48.
Zurück zum Zitat Venance SL, Cannon SC, Fialho D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006;129:8–17.CrossRefPubMed Venance SL, Cannon SC, Fialho D, et al. The primary periodic paralyses: diagnosis, pathogenesis and treatment. Brain. 2006;129:8–17.CrossRefPubMed
49.
Zurück zum Zitat Iorizzo LJ 3rd, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol. 2008;59:99–112.CrossRefPubMed Iorizzo LJ 3rd, Jorizzo JL. The treatment and prognosis of dermatomyositis: an updated review. J Am Acad Dermatol. 2008;59:99–112.CrossRefPubMed
50.
Zurück zum Zitat Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005;142:439–50.CrossRefPubMed Anderson KE, Bloomer JR, Bonkovsky HL, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med. 2005;142:439–50.CrossRefPubMed
51.
Zurück zum Zitat Grattan-Smith PJ, Morris JG, Johnston HM, et al. Clinical and neurophysiological features of tick paralysis. Brain. 1997;120(Pt 11):1975–87.CrossRefPubMed Grattan-Smith PJ, Morris JG, Johnston HM, et al. Clinical and neurophysiological features of tick paralysis. Brain. 1997;120(Pt 11):1975–87.CrossRefPubMed
52.
Zurück zum Zitat Edlow JA, McGillicuddy DC. Tick paralysis. Infect Dis Clin N Am. 2008;22:397–413.CrossRef Edlow JA, McGillicuddy DC. Tick paralysis. Infect Dis Clin N Am. 2008;22:397–413.CrossRef
53.
54.
Zurück zum Zitat Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ. Differences in clinical features between the Lambert–Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg. 2002;104:359–63.CrossRefPubMed Wirtz PW, Smallegange TM, Wintzen AR, Verschuuren JJ. Differences in clinical features between the Lambert–Eaton myasthenic syndrome with and without cancer: an analysis of 227 published cases. Clin Neurol Neurosurg. 2002;104:359–63.CrossRefPubMed
55.
Zurück zum Zitat Keogh M, Sedehizadeh S, Maddison P. Treatment for Lambert–Eaton myasthenic syndrome. Cochrane Database Syst Rev. 2011;16(2):CD003279. Keogh M, Sedehizadeh S, Maddison P. Treatment for Lambert–Eaton myasthenic syndrome. Cochrane Database Syst Rev. 2011;16(2):CD003279.
56.
Zurück zum Zitat Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns–Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol. 1991;48:1130–5.CrossRefPubMed Barohn RJ, Sahenk Z, Warmolts JR, Mendell JR. The Bruns–Garland syndrome (diabetic amyotrophy). Revisited 100 years later. Arch Neurol. 1991;48:1130–5.CrossRefPubMed
58.
Zurück zum Zitat Davies L, Spies JM, Pollard JD, McLeod JG. Vasculitis confined to peripheral nerves. Brain. 1996;119(Pt 5):1441–8.CrossRefPubMed Davies L, Spies JM, Pollard JD, McLeod JG. Vasculitis confined to peripheral nerves. Brain. 1996;119(Pt 5):1441–8.CrossRefPubMed
59.
Zurück zum Zitat Mathew L, Talbot K, Love S, Puvanarajah S, Donaghy M. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM. 2007;100:41–51.CrossRefPubMed Mathew L, Talbot K, Love S, Puvanarajah S, Donaghy M. Treatment of vasculitic peripheral neuropathy: a retrospective analysis of outcome. QJM. 2007;100:41–51.CrossRefPubMed
60.
Zurück zum Zitat London Z, Albers JW. Toxic neuropathies associated with pharmaceutic and industrial agents. Neurol Clin. 2007;25:257–76.CrossRefPubMed London Z, Albers JW. Toxic neuropathies associated with pharmaceutic and industrial agents. Neurol Clin. 2007;25:257–76.CrossRefPubMed
61.
Zurück zum Zitat Fox IK, Mackinnon SE. Adult peripheral nerve disorders: nerve entrapment, repair, transfer, and brachial plexus disorders. Plast Reconstr Surg. 2011;127:105e–18e.CrossRefPubMed Fox IK, Mackinnon SE. Adult peripheral nerve disorders: nerve entrapment, repair, transfer, and brachial plexus disorders. Plast Reconstr Surg. 2011;127:105e–18e.CrossRefPubMed
62.
Zurück zum Zitat Neal S, Fields KB. Peripheral nerve entrapment and injury in the upper extremity. Am Fam Physician. 2010;81:147–55.PubMed Neal S, Fields KB. Peripheral nerve entrapment and injury in the upper extremity. Am Fam Physician. 2010;81:147–55.PubMed
63.
67.
Zurück zum Zitat Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20:227–39.CrossRefPubMed Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin. 2002;20:227–39.CrossRefPubMed
68.
Zurück zum Zitat Sterns RH, Hix JK, Silver S. Treating profound hyponatremia: a strategy for controlled correction. Am J Kidney Dis. 2010;56:774–9.CrossRefPubMed Sterns RH, Hix JK, Silver S. Treating profound hyponatremia: a strategy for controlled correction. Am J Kidney Dis. 2010;56:774–9.CrossRefPubMed
69.
Zurück zum Zitat Ravid M, Robson M. Proximal myopathy caused by latrogenic phosphate depletion. JAMA. 1976;236:1380–1.CrossRefPubMed Ravid M, Robson M. Proximal myopathy caused by latrogenic phosphate depletion. JAMA. 1976;236:1380–1.CrossRefPubMed
70.
Zurück zum Zitat Sebastian S, Clarence D, Newson C. Severe hypophosphataemia mimicking Guillain–Barre syndrome. Anaesthesia. 2008;63:873–5.CrossRefPubMed Sebastian S, Clarence D, Newson C. Severe hypophosphataemia mimicking Guillain–Barre syndrome. Anaesthesia. 2008;63:873–5.CrossRefPubMed
71.
72.
Zurück zum Zitat Kiernan MC, Vucic S, Cheah BC, Turner MR, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.CrossRefPubMed Kiernan MC, Vucic S, Cheah BC, Turner MR, et al. Amyotrophic lateral sclerosis. Lancet. 2011;377:942–55.CrossRefPubMed
73.
Zurück zum Zitat Miller RG, Jackson CE, Kasarskis EJ, England JD, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review). Neurology. 2009;73:1227–33.CrossRefPubMedPubMedCentral Miller RG, Jackson CE, Kasarskis EJ, England JD, et al. Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review). Neurology. 2009;73:1227–33.CrossRefPubMedPubMedCentral
Metadaten
Titel
Emergency Neurological Life Support: Acute Non-traumatic Weakness
verfasst von
Anna Finley Caulfield
Oliver Flower
Jose A. Pineda
Shahana Uddin
Publikationsdatum
15.09.2017
Verlag
Springer US
Erschienen in
Neurocritical Care / Ausgabe Sonderheft 1/2017
Print ISSN: 1541-6933
Elektronische ISSN: 1556-0961
DOI
https://doi.org/10.1007/s12028-017-0450-3

Weitere Artikel der Sonderheft 1/2017

Neurocritical Care 1/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.